Product NDC: | 0409-1920 |
Proprietary Name: | Talwin |
Non Proprietary Name: | PENTAZOCINE LACTATE |
Active Ingredient(s): | 30 mg/mL & nbsp; PENTAZOCINE LACTATE |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0409-1920 |
Labeler Name: | Hospira, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA016194 |
Marketing Category: | NDA |
Start Marketing Date: | 20101012 |
Package NDC: | 0409-1920-10 |
Package Description: | 1 VIAL, MULTI-DOSE in 1 CARTON (0409-1920-10) > 10 mL in 1 VIAL, MULTI-DOSE |
NDC Code | 0409-1920-10 |
Proprietary Name | Talwin |
Package Description | 1 VIAL, MULTI-DOSE in 1 CARTON (0409-1920-10) > 10 mL in 1 VIAL, MULTI-DOSE |
Product NDC | 0409-1920 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | PENTAZOCINE LACTATE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
Start Marketing Date | 20101012 |
Marketing Category Name | NDA |
Labeler Name | Hospira, Inc. |
Substance Name | PENTAZOCINE LACTATE |
Strength Number | 30 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Competitive Opioid Antagonists [MoA],Partial Opioid Agonist/Antagonist [EPC],Partial Opioid Agonists [MoA] |